Age-related macular degeneration is a leading cause of blindness and affects over 196 million people worldwide. Despite its prevalence, very little is known about the causes or mechanisms of this ...

An estimated 80 percent of patients with the wet form of macular degeneration are diagnosed too late for effective treatment. Now, there's a new computerized test that can detect it earlier than ever ...

Age-related macular degeneration (AMD) is one the most prevalent eye diseases. In the late stage of the disease, newly formed vessels in the retina alter its structure, which leads to blurry and ...

Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity by microperimetry can indicate different stages of disease ...

Early AMD gives no warning. These are the vision changes to watch for.

Ophthalmologists at UC Davis Health used an experimental gene therapy last month to treat a patient with wet age-related macular degeneration, or wet AMD. It was the first time the UC Davis Eye Center ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

Medically reviewed by Christine L. Larsen, MD Key Takeaways Macular degeneration is a common eye disease, affecting more than ...

A phase 2 clinical trial is underway at Columbia University and NewYork-Presbyterian to test an investigational gene therapy for dry age-related macular degeneration, a progressive, chronic eye ...

Macular degeneration is the leading cause of vision loss in people older than 65. Smoking doubles your risk of macular degeneration compared to non-smokers. Your risk of the disease increases if you ...